B-cell ALL

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:Oncology
gptkbp:affects gptkb:B_lymphocytes
gptkbp:age_group gptkb:children
young adults
gptkbp:associated_with gptkb:Philadelphia_chromosome
central nervous system involvement
hyperleukocytosis
gptkbp:clinical_trial gptkb:immunotherapy
targeted therapies
new therapies
gptkbp:common_treatment_regimen maintenance therapy
consolidation therapy
induction therapy
gptkbp:complication gptkb:disease
organ damage
bleeding disorders
gptkbp:death lower in adults
higher in children
gptkbp:diagnosis gptkb:CD22
gptkb:CD19
blood tests
varies by age
bone marrow biopsy
Td T
varies by genetic factors
gptkbp:events psychosocial support
regular blood tests
monitoring for relapse
https://www.w3.org/2000/01/rdf-schema#label B-cell ALL
gptkbp:is_common_in males
Caucasian populations
African American populations
Hispanic populations
gptkbp:is_involved_in gptkb:Leukemia_&_Lymphoma_Society
gptkb:Cancer_Support_Community
local cancer support groups
gptkbp:research_focus genetic mutations
long-term effects of treatment
treatment resistance
gptkbp:risk_factor genetic disorders
exposure to radiation
previous chemotherapy
gptkbp:symptoms fatigue
weight loss
fever
pale skin
easy bruising
gptkbp:treatment gptkb:Medicine
radiation therapy
chemotherapy
remission
stem cell transplant
gptkbp:type_of gptkb:Burkitt_leukemia
gptkb:Ph-positive_ALL
gptkb:Precursor_B-cell_ALL
gptkbp:bfsParent gptkb:Oncology
gptkbp:bfsLayer 4